Evidence map›Paper›PMID 31196966›Full record

SynthesisBioscience reports2019

Investigation of

Guoxiang Rong, Weifeng Tang, Yafeng Wang, Hao Qiu, Shuchen Chen

Open access · goldAbstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Susceptibility ofTechnology in cancer research & treatment
    Pooled it
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Guoxiang RongDepartment of Thoracic Surgery, The People's Hospital of Danyang, Danyang, Jiangsu Province, China.
Weifeng TangDepartment of Cardiothoracic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.ORCID 0000-0002-4157-4057
Yafeng WangDepartment of Cardiology, The People's Hospital of Xishuangbanna Dai Autonomous Prefecture, Jinghong, Yunnan Province, China.
Hao QiuInstitute of Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China.
Shuchen ChenDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China chenshuchen@fjmu.edu.cn.
Jiangsu University · CNFujian Medical University · CNFuyang City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptin receptor (LEPR) signaling may be involved in promoting angiogenesis and proliferation, inhibiting apoptosis and playing a vital role in the progression of carcinogenesis. A number of studies have focused on the association of

Indexed as

Polymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansMouth NeoplasmsNeoplasmsOdds RatioOropharyngeal NeoplasmsReceptors, LeptinRiskLEPR protein, humanReceptors, Leptincancerenergyleptinpolymorphismreceptorrisk

Identifiers

PMID31196966
PMCPMC6597850
OpenAlexW2949504486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.